Synonyms Large B-cell lymphoma subtype primary mediastinal (Thymic) large B-cell lymphoma recurrent, Primary mediastinal large B-cell lymphoma recurrent, Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma + [11] |
Introduction The reemergence of primary mediastinal large B-cell lymphoma after a period of remission. |
Target |
Mechanism CD19 modulators [+1] |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest PhaseApproved |
First Approval Ctry. / Loc. US |
First Approval Date05 Feb 2021 |
Target |
Mechanism IL-15Rα agonists |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2/3 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Target |
Mechanism CD19 inhibitors |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 1 |
First Approval Ctry. / Loc.- |
First Approval Date20 Jan 1800 |
Start Date29 Jan 2024 |
Sponsor / Collaborator |
Start Date29 Jun 2023 |
Sponsor / Collaborator |
Start Date08 Dec 2022 |
Sponsor / Collaborator |